- Home
- PFLT vs SVA Comparison
PFLT vs SVA Comparison
Compare PFLT & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFLT
- SVA
- Stock Information
- Founded
- PFLT 2010
- SVA N/A
- Country
- PFLT United States
- SVA
- Employees
- PFLT N/A
- SVA 3261
- Industry
- PFLT Finance: Consumer Services
- SVA
- Sector
- PFLT Finance
- SVA
- Exchange
- PFLT Nasdaq
- SVA NYSE
- Market Cap
- PFLT 838.8M
- SVA N/A
- IPO Year
- PFLT N/A
- SVA N/A
- Fundamental
- Price
- PFLT $11.46
- SVA $6.47
- Analyst Decision
- PFLT Strong Buy
- SVA
- Analyst Count
- PFLT 2
- SVA 0
- Target Price
- PFLT $12.00
- SVA N/A
- AVG Volume (30 Days)
- PFLT 635.8K
- SVA N/A
- Earning Date
- PFLT 11-25-2024
- SVA N/A
- Dividend Yield
- PFLT 10.71%
- SVA N/A
- EPS Growth
- PFLT N/A
- SVA N/A
- EPS
- PFLT 1.60
- SVA N/A
- Revenue
- PFLT $166,565,000.00
- SVA N/A
- Revenue This Year
- PFLT $29.07
- SVA N/A
- Revenue Next Year
- PFLT $14.55
- SVA N/A
- P/E Ratio
- PFLT $7.18
- SVA N/A
- Revenue Growth
- PFLT 25.81
- SVA N/A
- 52 Week Low
- PFLT $9.69
- SVA N/A
- 52 Week High
- PFLT $12.63
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- PFLT 43.78
- SVA N/A
- Support Level
- PFLT $11.67
- SVA N/A
- Resistance Level
- PFLT $11.90
- SVA N/A
- Average True Range (ATR)
- PFLT 0.14
- SVA 0.00
- MACD
- PFLT -0.01
- SVA 0.00
- Stochastic Oscillator
- PFLT 6.32
- SVA 0.00
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.